Right to Receive Royalties Sample Clauses

The "Right to Receive Royalties" clause establishes a party’s entitlement to receive payments based on the use, sale, or licensing of intellectual property or other assets. Typically, this clause outlines the conditions under which royalties are earned, the calculation method, and the payment schedule, such as quarterly or annual disbursements. By clearly defining who is owed royalties and under what circumstances, this clause ensures that creators or rights holders are fairly compensated for the ongoing use of their work, thereby preventing disputes and providing financial clarity.
Right to Receive Royalties. I understand that if I assign my intellectual property rights to Sponsor, then Sponsor will manage the intellectual property and shall be solely responsible for patenting and commercialization of the intellectual property. Sponsor shall have the sole right and responsibility to determine the extent of United States and foreign patent prosecution, maintenance, enforcement and defense relating to the intellectual property. I understand that if I assign my intellectual property rights to Sponsor, then I will not receive any financial benefit, licensing or patenting assistance, or other financial compensation from the University for that Intellectual Property. Any financial benefit would have to be agreed to in a separate agreement with Sponsor.
Right to Receive Royalties. I understand that if I assign my Intellectual Property to Sponsor, then Sponsor will manage the Intellectual Property and shall be solely responsible for patenting and commercialization of the Intellectual Property. Sponsor shall have sole right and responsibility to determine the extent of United States and foreign patent prosecution, maintenance, enforcement and defense relating to the Intellectual Property.
Right to Receive Royalties. I understand that if I assign my intellectual property rights to the KSURF, then KSURF will manage the intellectual property under current University policy and will share resulting
Right to Receive Royalties. I understand that if I assign my intellectual property rights to the University, then NTU will manage the intellectual property under current University policy and will share resulting royalties, if any, with me in accordance with University policy as it applies to intellectual property created by University employees. NTU shall be solely responsible for patenting and commercialization of the intellectual property, consistent with University policy, as may be amended from time to time, and shall have sole right and responsibility to determine the extent of patent prosecution, maintenance, enforcement and defense relating to the intellectual property. NTU is under no obligation to use other than reasonable efforts currently in practice in the future marketing or licensing of the intellectual property.
Right to Receive Royalties. As of January 1, 2000, the parties agree that -------------------------- all royalty payments made pursuant to the PDGF Agreement shall be made directly to ZGI, or shall be delivered by NN to ZGI if the royalty payments are or were made to NN. NN hereby irrevocably and unconditionally waives any right to receive such royalty payments.
Right to Receive Royalties. Should any other products containing the Thymosin Beta 4 be sold in any country of the Territory by any other third parties and should the Sales of the Finished Product be affected by such competing products, the parties shall meet to discuss in good faith how best to proceed, ***. Additionally, Defiante shall ensure that any obligations of Sub-Licensees to pay royalties shall be the responsibility and obligation of Defiante and that Defiante shall assume the entire liability therefore consistent with the requirements hereunder.
Right to Receive Royalties. Should any other products containing the Thymosin Beta 4 be sold in any country of the Territory by any other third parties and should the Sales of the Finished Product be affected by such competing products, the parties shall meet to discuss in good faith how best to proceed, including a revision ***. Defiante acknowledges that regardless of whether *** or is subject to an adjustment *** that the obligation to pay royalties and fees as recited herein shall *** right of RegeneRx to receive royalties shall *** even, but not limited to, with respect ***. Additionally, Defiante shall ensure that any obligations of Sub-Licensees to pay royalties shall be the responsibility and obligation of Defiante and that Defiante shall assume the entire liability therefore consistent with the requirements hereunder.
Right to Receive Royalties. I understand that Sponsor will manage the intellectual property and be solely responsible for patenting and commercializing the intellectual property. Sponsor shall have the sole right and responsibility to determine the extent of United States and foreign patent prosecution, maintenance, enforcement and defense relating to the intellectual property. I understand that I will not receive any financial benefit or other financial compensation from the University or Sponsor for the intellectual property, unless Sponsor agrees in writing to provide a financial benefit to me. I will make myself available to Sponsor’s patent attorneys as may be necessary for Sponsor to secure and maintain patents to the intellectual property in any and all countries and for vesting title thereto in Sponsor. At Sponsor’s written request, and at Sponsor’s expense, I will promptly provide Sponsor, or sign for Sponsor, any additional documents necessary. I understand that I will be named as an inventor on any patent application and resulting patent sought by the Sponsor for the intellectual property. I understand that my responsibilities to cooperate in the patenting process under this agreement may continue after completion of the course and possibly even after my graduation from the University.
Right to Receive Royalties. I understand that if I assign my intellectual property rights to the University, then The Penn State Research Foundation (PSRF) will manage the intellectual property under current University policy and will share resulting royalties, if any, with me in accordance with University policy as it applies to intellectual property created by University employees. PSRF shall be solely responsible for patenting and commercialization of the intellectual property, consistent with University policy, as may be amended from time to time, and shall have sole right and responsibility to determine the extent of United States and foreign patent prosecution, maintenance, enforcement and defense relating to the intellectual property. PSRF is under no obligation to use other than reasonable efforts currently in practice in the future marketing or licensing of the intellectual property.

Related to Right to Receive Royalties

  • Payment of Royalties To the best of Seller’s knowledge, all royalties and in-lieu royalties with respect to the Assets which accrued or are attributable to the period prior to the Effective Time have been properly and fully paid, or are included within the suspense amounts being conveyed to Buyer pursuant to Section 11.4.

  • Earned Royalties In partial consideration of the License and subject to Sections 3.7 and 3.8, Company will pay to Penn: (i) a graduated royalty as set forth in the table below based upon worldwide annual Net Sales made by Company and its Affiliates (but not sublicensees) of any Designated Compound Sold for use in the Field of Use while covered in the country of Sale of expected use by a Valid Claim of the Assigned BMS Patents that is licensed to Company under the License (but no other Licensed Product): <$500 million [CONFIDENTIAL TREATMENT REQUESTED] /*/% >$500 million but <$750 million [CONFIDENTIAL TREATMENT REQUESTED] /*/% >$750 million but <$1 billion [CONFIDENTIAL TREATMENT REQUESTED] /*/% >$1 billion [CONFIDENTIAL TREATMENT REQUESTED] /*/% [CONFIDENTIAL TREATMENT REQUESTED] /*/ PATENT LICENSE AGREEMENT (ii) a royalty of [CONFIDENTIAL TREATMENT REQUESTED] /*/ percent ([CONFIDENTIAL TREATMENT REQUESTED] /*/%) of Net Sales made by Company and its Affiliates (but not sublicensees) for all Licensed Products that qualify as “Licensed Products” hereunder based on clause (b) of that definition and Sold while covered in the country of Sale of expected use by a Valid Claim of the Penn Existing Patents or Penn New Patents; provided that, notwithstanding any credits provided for in Section 3.7 but subject in all events to Section 3.8, royalties payable by Company for such Net Sales for such Licensed Products shall not be less than [CONFIDENTIAL TREATMENT REQUESTED] /*/ percent ([CONFIDENTIAL TREATMENT REQUESTED] /*/%). Only one royalty shall be due hereunder on the Sale of the same unit of Licensed Product. If a royalty accrues to a Sale of a Licensed Product under both clause (i) and (ii) above, then the higher rate of clause (i) shall apply. Only one royalty shall be due hereunder on the Sale of a Licensed Product even if the manufacture, use, sale, offer for sale or importation of such Licensed Product infringes more than one Valid Claim of the Penn Patent Rights.

  • Right to Receive Advice (a) Advice of the Fund. If PNC Bank is in doubt as to any action it should or should not take, PNC Bank may request directions or advice, including Oral or Written Instructions, from the Fund.

  • Payment of Royalty The royalty obligation under Section 5.4 shall accrue upon the sales of a Licensed Product in each particular country in the Territory, commencing upon [***], and such obligation shall end upon the expiration of the Royalty Term applicable to such Licensed Product in such country. All such royalty payments are non-refundable and non-creditable and shall be due within [***] days of the end of each [***] and are payable in immediately available funds. ProNAi shall notify Marina in writing promptly upon the First Commercial Sale of Licensed Product in each country and thereafter ProNAi shall furnish Marina with a written report (the “Royalties Report”) for each completed [***] showing, on a country-by-country basis, according to the volume of units of Licensed Product sold in each such country (by SKU) during the reporting period (whether Licensed Product is sold by ProNAi or its Affiliates or Sublicensees): (a) the gross invoiced sales of the Licensed Product sold in each country during the reporting period, and the amounts deducted therefrom to determine Net Sales from such gross invoiced sales; (b) the royalties payable in dollars, if any, which shall have accrued hereunder based upon Net Revenues from sales of Licensed Product; and (c) the withholding taxes, if any, required by Applicable Law to be deducted in respect of such sales (provided that, as to sales by Sublicensees, ProNAi shall report only the net sales numbers (using the definition for such term in the applicable sublicense agreement) as reported by the Sublicensee, if such Sublicensee does not report gross invoiced sales numbers). With respect to sales of Licensed Product invoiced in US dollars, the gross invoiced sales, Net Revenues and royalties payable shall be expressed in the Royalties Report in US Dollars. With respect to sales of Licensed Product invoiced in a currency other than US dollars, the gross invoiced sales, Net Sales and royalties payable shall be expressed in the Royalties Report in the domestic currency of the party making the sale as well as in the US dollar equivalent of the Royalty payable and the exchange rate used in determining the amount of US dollars. The US dollar equivalent shall be calculated on a calendar-month basis using the average monthly interbank rate listed in the Wall Street Journal.

  • OUR RIGHT TO RECOVER PAYMENT If we make a payment under this policy and the person to or for whom payment was made has a right to recover damages from another we shall be subrogated to that right. That person shall do: